Publicaciones en colaboración con investigadoras/es de University of Eastern Finland (5)

2012

  1. Differences in brain cholesterol metabolism and insulin in two subgroups of patients with different CSF biomarkers but similar white matter lesions suggest different pathogenic mechanisms

    Neuroscience Letters, Vol. 510, Núm. 2, pp. 121-126

  2. Grey matter and cognitive patterns in cognitive impaired subjects using CSF biomarker cut-offs

    Journal of Alzheimer's Disease, Vol. 29, Núm. 4, pp. 741-749

2010

  1. Effect of nateglinide on the incidence of diabetes and cardiovascular events

    New England Journal of Medicine, Vol. 362, Núm. 16, pp. 1463-1476

  2. Effect of valsartan on the incidence of diabetes and cardiovascular events

    New England Journal of Medicine, Vol. 362, Núm. 16, pp. 1477-1490

2009

  1. Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease

    Neuroscience Letters, Vol. 462, Núm. 1, pp. 89-93